Dr. Jekyll or Mr. Hyde? The duality of Streptococcus sanguinis as friend and foe.

杰基尔博士还是海德先生?

基本信息

  • 批准号:
    9895893
  • 负责人:
  • 金额:
    $ 26.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-01-22 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Streptococcus sanguinis is an abundant member of the oral microbiota and a promising oral probiotic since it has been associated with oral health in humans and shown to compete with oral pathogens. Conversely, S. sanguinis is also an important cause of bacterial endocarditis, a serious infection of the heart that affects >40,000 people in the U.S each year and has mortality rates exceeding 20%. Endocarditis is of critical concern to U.S dentists, who typically provide antibiotic prophylaxis to high-risk patients prior to invasive dental procedures. The underlying cause of the duality in S. sanguinis lifestyle as a health-associated commensal or a serious pathogen is poorly understood. Delineation of the S. sanguinis factors that are important for oral health versus endocarditis virulence would facilitate the development of efficacious and safe probiotics, and more targeted prophylactics against endocarditis during dental procedures. A significant barrier to progress in the field is the paucity of genetically-, epigenetically-, or phenotypically- characterized isolates. Numerous studies have employed a variety of poorly characterized strains, many of which are no longer classified as S. sanguinis, making it difficult to assess findings. Moreover, related Streptococcus species are notoriously genetically diverse, and additional epigenetic mechanisms have been demonstrated to drive phenotypic diversity and virulence even within clonal populations. Although the complete genome of SK36 has been published, its epigenetic profile (i.e. methylome) is unknown and, regardless, no single strain can capture the true capabilities of the species. This proposal will surmount these barriers by first using single-molecule real-time (SMRT) sequencing to generate complete genomes/epigenomes of 40 bona fide S. sanguinis strains, representing both oral and endocarditis isolates. This will reveal the core and accessory genomes related to oral and endocarditis environmental niches, in addition to the methylome of each isolate. The central hypothesis of this proposal is that the dual lifestyle of S. sanguinis is either A) facilitated by the presence or absence of specific genetic loci (i.e. virulence genes, islands, or plasmids) or B) epigenetically encoded and induced by transcriptomic alterations within permissive environmental niches. An in-vivo endocarditis model will be used to screen for infective endocarditis virulence and test whether targeted reengineered isogenic mutants are deficient for virulence, making them suitable candidates for development as oral probiotics. The immediate outcomes will be an S. sanguinis strain collection that is genetically-, epigenetically-, and phenotypically defined and which will be made available to the research community, and the ascertainment of whether S. sanguinis endocarditis virulence is genetically or epigenetically encoded. The long-term outcome will be the creation of strains engineered to have low endocarditis virulence. If virulence is controlled epigenetically in S. sanguinis as it is in some of its closest relatives, the loss of endocarditis virulence will be accompanied by an increase in oral competitiveness, making these strains ideal for oral probiotic development.
摘要血链球菌是口腔菌群中数量最多的一种,是一种很有前途的口腔致病菌 益生菌,因为它已经与人类的口腔健康有关,并显示出与口腔病原体竞争。 相反,S.血吸虫也是细菌性心内膜炎的重要原因,这是一种严重的心脏感染 在美国,每年有超过40,000人受到影响,死亡率超过20%。心内膜炎是 美国牙医的严重关切,他们通常在侵入性治疗之前为高危患者提供抗生素预防。 牙科手术。S. sanguinis的生活方式作为一个健康相关的 对细菌或严重的病原体知之甚少。S.血统因素, 重要的口腔健康与心内膜炎的毒力将有助于发展有效和安全的 益生菌和更有针对性的抗心内膜炎药物在牙科手术。一个重大障碍 该领域的进展是缺乏遗传学、表观遗传学或表型特征的分离物。 许多研究采用了各种特征不佳的菌株,其中许多不再是 分类为S.这使得很难评估调查结果。此外,相关的链球菌属物种是 众所周知的遗传多样性,和其他表观遗传机制已被证明是驱动 表型多样性和毒性,甚至在克隆种群。尽管SK36的完整基因组 尽管已经发表,但其表观遗传特征(即甲基化组)是未知的,并且无论如何,没有单一菌株可以捕获 物种的真正能力。这项提议将首先利用单分子 实时(SMRT)测序以产生40个真正的S.血吸虫菌株, 代表口腔和心内膜炎分离株。这将揭示核心和附属基因组相关, 口腔和心内膜炎的环境小生境,除了每个分离物的甲基化组。中央 这一建议的假设是,双重生活方式的S。A)通过存在或 缺乏特定的遗传基因座(即毒力基因、毒力岛或质粒)或B)表观遗传编码, 由允许的环境小生境内的转录组学改变诱导。体内心内膜炎模型 将用于筛选感染性心内膜炎毒力,并测试是否有针对性的重组等基因 突变体缺乏毒力,使它们成为开发为口服益生菌的合适候选者。的 直接结果是S。sanguinis菌株收集,其在遗传学上、表观遗传学上和 表型定义,并将提供给研究界,并确定 无论是S.血吸虫心内膜炎毒力是遗传或表观遗传编码的。长期结果 将是创造具有低心内膜炎毒力的工程菌株。如果毒力得到控制 表观遗传学上S.由于它是在一些最接近的亲属,心内膜炎毒力的损失将是 伴随着口服竞争力的增加,使这些菌株成为口服益生菌开发的理想选择。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TODD O. KITTEN其他文献

TODD O. KITTEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TODD O. KITTEN', 18)}}的其他基金

Oral Streptococcal Fitness And Virulence genes
口腔链球菌适应性和毒力基因
  • 批准号:
    10662278
  • 财政年份:
    2021
  • 资助金额:
    $ 26.81万
  • 项目类别:
Oral Streptococcal Fitness And Virulence genes
口腔链球菌适应性和毒力基因
  • 批准号:
    10296913
  • 财政年份:
    2021
  • 资助金额:
    $ 26.81万
  • 项目类别:
Oral Streptococcal Fitness And Virulence genes
口腔链球菌适应性和毒力基因
  • 批准号:
    10461116
  • 财政年份:
    2021
  • 资助金额:
    $ 26.81万
  • 项目类别:
Role of metal transport in Streptococcus sanguinis virulence and competitiveness
金属转运在血链球菌毒力和竞争力中的作用
  • 批准号:
    8963500
  • 财政年份:
    2015
  • 资助金额:
    $ 26.81万
  • 项目类别:
Role of metal transport in Streptococcus sanguinis virulence and competitiveness
金属转运在血链球菌毒力和竞争力中的作用
  • 批准号:
    9089888
  • 财政年份:
    2015
  • 资助金额:
    $ 26.81万
  • 项目类别:
Endocarditis virulence in Streptococcus sanguinis
血链球菌心内膜炎毒力
  • 批准号:
    8293463
  • 财政年份:
    2011
  • 资助金额:
    $ 26.81万
  • 项目类别:
Streptococcal genomics and pathogenesis
链球菌基因组学和发病机制
  • 批准号:
    6875252
  • 财政年份:
    2003
  • 资助金额:
    $ 26.81万
  • 项目类别:
Streptococcal genomics and pathogenesis
链球菌基因组学和发病机制
  • 批准号:
    7197979
  • 财政年份:
    2003
  • 资助金额:
    $ 26.81万
  • 项目类别:
Streptococcal genomics and pathogenesis
链球菌基因组学和发病机制
  • 批准号:
    6605214
  • 财政年份:
    2003
  • 资助金额:
    $ 26.81万
  • 项目类别:
Streptococcal genomics and pathogenesis
链球菌基因组学和发病机制
  • 批准号:
    6750123
  • 财政年份:
    2003
  • 资助金额:
    $ 26.81万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 26.81万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 26.81万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 26.81万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了